entri
envelop
virus
depend
sever
cellular
compon
includ
protein
carbohydr
receptor
oftentim
coreceptor
bind
virus
cell
catalyz
initi
stage
viral
surfac
protein
refold
endocytosi
common
prerequisit
success
entri
acid
ph
proteas
endosom
creat
structur
chang
viral
protein
mediat
cell
receptor
bind
viruscel
membran
fusion
final
appropri
lipid
environ
often
abund
sterol
also
frequent
necessari
achiev
facil
fusion
viral
cellular
membran
numer
semin
investig
step
dissect
block
viru
entri
mutant
transgen
drug
alter
receptor
endosom
lipid
environ
although
power
approach
find
complic
transgen
drug
creat
untoward
pleiotrop
chang
cellular
function
complementari
reductionist
approach
involv
vitro
viru
entri
envelop
virus
bound
fuse
synthet
liposom
testtub
reaction
receptor
ph
proteas
liposom
bilay
composit
precis
defin
freeli
alter
way
achiev
live
cell
system
use
adjunct
understand
biochemistri
envelop
viru
entri
vitro
virusliposom
bind
assay
recent
develop
murin
coronavirus
studi
purifi
mhv
particl
acquir
hydrophob
charact
incub
solubl
mhv
receptor
exposur
elev
ph
thu
caus
small
proport
viru
popul
associ
liposom
aim
advanc
studi
creat
liposom
close
reflect
authent
mhvsuscept
cell
end
creat
synthet
liposom
contain
nickelnitriloacet
acid
ninta
adduct
fraction
lipid
head
group
solubl
mhv
receptor
contain
engin
polyhistidin
tag
could
attach
liposom
therebi
creat
artifici
target
viru
bind
liposom
attach
receptor
use
identifi
requir
irrevers
associ
mhv
target
membran
entri
product
dogsntani
contain
chelat
ni
nta
head
group
noncoval
complex
polyhistidin
tag
lipid
variou
formul
typic
mole
ratio
phosphatidylcholin
pc
cholesterol
chol
dogsninta
suspend
dri
state
hepesbuff
salin
extrud
polycarbon
filter
creat
liposom
liposom
mix
baculovirusexpress
solubl
mhv
receptor
contain
ctermin
tag
solubl
receptor
design
solubl
carcinoembryonicantigen
remov
unbound
receptor
adjust
mixtur
contain
wv
sucros
overlaid
stepwis
wv
sucros
solut
float
liposom
sucros
interfac
ultracentrifug
liposom
complex
collect
store
c
estim
concentr
titrat
immunoblot
indic
typic
prepar
densiti
scea
per
liposom
metabolicallyradiolabel
mhv
particl
purifi
equilibrium
densiti
gradient
sediment
typic
incub
cpm
mhv
pfu
h
c
mm
phospholipid
liposom
volum
hepesbuff
salin
mixtur
brought
sucros
subject
second
round
ultracentrifug
float
liposom
identifi
contain
gradient
fraction
determin
mhv
bind
liposom
absolut
depend
ninta
lipid
fig
notabl
control
sceafc
lack
tag
bound
virion
fail
link
virion
liposom
fig
even
incub
c
determin
whether
connect
mhv
liposom
revers
exploit
common
knowledg
noncoval
linkag
disrupt
edta
imidazol
end
harvest
mhvliposom
complex
gradient
fraction
ad
edta
mm
final
concentr
min
c
reflot
fresh
sucros
gradient
reveal
edta
exposur
separ
virion
leav
near
bottom
ultracentrifug
tube
fig
howev
mhvliposom
complex
incub
min
c
insensit
dissoci
edta
fig
discoveri
allow
us
conclud
physiolog
temperatur
requir
establish
edtaresist
linkag
viru
target
lipid
bilay
mhv
entri
requir
cholesterol
target
lipid
bilay
determin
whether
irrevers
virusliposom
linkag
requir
cholesterol
prepar
liposom
lack
contain
cholesterol
two
liposom
formul
indistinguish
irrevers
c
temperaturedepend
captur
mhv
particl
fig
coronaviru
particl
distinguish
promin
spike
protein
trimer
glycoprotein
bind
cell
receptor
mediat
viruscel
membran
fusion
fusion
reaction
pathway
class
type
refold
helic
bundl
product
process
refold
preced
involv
temperaturedepend
insert
hydrophob
spike
peptid
socal
fusion
peptid
target
membran
current
hypothes
stabil
associ
mhv
synthet
liposom
result
insert
fusion
peptid
liposom
membran
hypothesi
born
suggest
intercal
fusion
peptid
strongli
temperaturedepend
requir
cholesterol
target
membran
assess
whether
bonafid
fusion
viru
liposom
membran
occur
princip
strategi
monitor
fluoresc
chang
pyren
lipid
probe
redistribut
limit
membran
larger
area
fuse
vesicl
despit
numer
attempt
yet
document
mhv
liposom
coalesc
method
entir
possibl
compon
requir
complet
mhv
membran
fusion
process
miss
vitro
assay
fusion
may
requir
exposur
acid
proteas
may
requir
proteinac
cofactor
addit
princip
cea
receptor
like
also
requir
specif
sterolcontain
lipid
environ
continu
investig
identifi
condit
may
allow
complet
spikemedi
class
fusion
pathway
thank
dr
fumihiro
taguchi
nation
institut
infecti
diseas
tokyo
japan
provid
baculoviru
recombin
encod
work
fund
ph
grant
nih
